[ad_1]
DUBLIN, Dec. 28, 2022 /PRNewswire/ — The “In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022″ report has been added to ResearchAndMarkets.com’s providing.
This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore.
The Asia Pacific (APAC) area is a fast-growing in vitro diagnostics (IVD) market, which is witnessing rising focus by main international gamers out there. Southeast Asia has been recognized as one of many key areas in APAC area providing vital alternatives for IVD corporations.
These three international locations collectively symbolize a fast-growing geographic area providing vital alternative for IVD corporations. The overall inhabitants of those three international locations is over 310 million, which is near the inhabitants in the US.
Amongst these three international locations, Singapore has established world class healthcare service capabilities by way of infrastructure in addition to expert manpower. Although the inhabitants is lower than 6 million, the Singapore market is engaging for IVD corporations and it has develop into a medical tourism hub within the area.
Indonesia, however, is a rustic with an enormous inhabitants of about 275 million folks. The nation is taking vital steps to enhance its healthcare infrastructure, which is providing appreciable alternatives for IVD corporations.
The Malaysian market, with a inhabitants of about 32 million falls in between these two international locations, each by way of healthcare service capabilities and development potentials.
In Vitro Diagnostics (IVD) in Malaysia, Singapore, and Indonesia, 2022 covers the next segments:
The report additionally profiles key corporations out there:
-
Abbott Diagnostics
-
ARKRAY
-
Beckman Coulter, Inc. / Danaher
-
Becton, Dickinson, and Firm (BD)
-
BioCytech Company
-
bioMerieux Inc.
-
Bio-Rad Laboratories, Inc.
-
Caris Life Sciences
-
Cephei
-
CTK Biotech Inc
-
Danaher Company
-
Dexcom
-
DiaSorin S.p.A
-
Grifols S.A.
-
Healgen Scientific LLC
-
Hologic, Inc.
-
Horiba Medical
-
Lucence Diagnostics
-
Medical Innovation Ventures Sdn. Bhd. (Mediven)
-
Mindray (Shenzhen Mindray Bio-medical Electronics Co., Ltd.)
-
MiRXES Pte Ltd.
-
OraSure Applied sciences, Inc.
-
Ortho Scientific Diagnostics (Ortho)
-
PerkinElmer, Inc. (PE)
-
QIAGEN
-
Reszon Diagnostics Worldwide
-
Roche Diagnostics
-
Sysmex Company
-
Vela Diagnostics
-
Veredus Laboratories Pte Ltd
Key Subjects Coated:
Chapter 1: Government Abstract
-
Malaysia: Healthcare and Regulatory Panorama
-
Regulation of Medical gadgets in Malaysia
-
IVD Market Dimension Estimation and Forecast for Malaysia
-
Indonesia: Healthcare and Regulatory Panorama
-
Market Drivers and Challenges
-
The Well being Insurance coverage System
-
Insurance policies on Procurement, Import, Market Authorization, and Halal Certification of IVDs
-
IVD Market Dimension Estimation and Forecast for Indonesia
-
Singapore: Healthcare and Regulatory Panorama
-
The Well being Insurance coverage System
-
Insurance policies on Import, Registration, and Distribution of IVDs in Singapore
-
Restoration of the Medical Tourism Sector
-
IVD Market Dimension Estimation and Forecast for Singapore
-
The Mixed IVD Markets of Malaysia, Indonesia, and Singapore
-
Complete IVD Market Dimension in Malaysia, Indonesia, and Singapore and Forecasts, 2022-2027 ($ Tens of millions)
-
Market Shares of the Main IVD Firms (Roche, Abbott, Siemens Healthineers, Beckman Coulter, bioMerieux, Bio-Rad, Sysmex, and Others) in Malaysia, Indonesia, and Singapore, 2022
Chapter 2: COVID-19 Testing Market Traits
-
COVID-19 Testing Traits in Malaysia (2020-2022)
-
COVID-19 Testing Traits in Indonesia (2020-2022)
-
COVID-19 Testing Traits in Singapore (2020-2022)
Chapter 3: Level-of-Care Exams
-
Being pregnant and Fertility Testing
-
Most cancers Testing
-
Lipid Testing
-
Drug of Abuse (DOA) Testing
-
Infectious Illness Testing
-
HIV
-
Hepatitis
-
Tuberculosis (TB)
-
Tropical Ailments
-
Dengue
-
Filariasis
-
Leptospirosis
-
Malaria
-
Typhoid
-
Respiratory Ailments
-
Sexual Well being
-
Diabetes Testing – Blood Glucose Monitoring
-
Different POC exams
Chapter 4: Core Lab and Scientific Chemistry
-
Workstation Consolidation and Laboratory Automation
-
Core Lab: Market Evaluation
-
Scientific Chemistry Market Evaluation
-
Blood Gases and Electrolytes
-
Urinalysis
Chapter 5: Immunoassays
Chapter 6: Molecular Assays
-
Oncology
-
Genetic Ailments and Problems
-
Prenatal Testing, Pre-Implantation Genetic Testing, and so on.
-
Transplant Diagnostics
-
Main Firms (Roche, Abbott, QIAGEN, and Others) within the Molecular Diagnostics (Non-Infectious Ailments) Markets in Malaysia, Indonesia, and Singapore, 2022
Chapter 7: Hematology
-
Laboratory-based Hematology: Know-how and Market Traits
-
Main Firms (Sysmex, Beckman Coulter/Danaher, Mindray, Roche, and Others) within the Laboratory-based Hematology Markets in Malaysia, Indonesia, and Singapore, 2022
Chapter 8: Coagulation
Chapter 9: Microbiology and Virology
-
Antibiotic Resistant Infections: Challenges and Options
-
Syndromic Testing
-
Prognosis of Prevalent Infectious Ailments in Malaysia, Indonesia, and Singapore
-
Hepatitis Testing
-
Sepsis and Hospital Acquired Infections (HAI) Testing
-
HIV Testing
-
Sexually Transmitted Ailments (STDs) Testing
-
ToRCH
-
Respiratory An infection Testing
-
Scientific Microbiology and Virology Market Segments
-
Tuberculosis (TB) Testing
-
Different Prevalent Infectious Ailments and their Prognosis in Malaysia, Indonesia, and Singapore
-
ID/AST: Market Evaluation
-
ID/AST Programs: Panels, Auto, and Provides
-
Blood Tradition
-
Chromogenic Media
-
Fast Exams Carried out on Colonies from Tradition Media
Chapter 10: Blood Banking Providers
-
Blood Typing and Grouping
-
Blood Testing
-
Market Traits Triggered by COVID-19 Pandemic
-
Blood Banking Service Markets in Malaysia
-
Blood Banking Service Markets in Indonesia
-
Blood Banking Service Markets in Singapore
Chapter 11: Histology and Cytology
-
HPV Testing: A Quick-Rising Market Phase
-
Technological Developments in Histology and Cytology
-
Market Traits
-
Histology and Cytology Markets in Malaysia
-
Digital Pathology Options in Malaysia
-
Histology and Cytology Markets in Indonesia
-
Digital Pathology Options in Indonesia
-
Histology and Cytology Markets in Singapore
-
Digitization of Histology Laboratories in Singapore
Chapter 12: Firm Profiles
For extra details about this report go to https://www.researchandmarkets.com/r/k5ag4z
Media Contact:
Analysis and Markets
Laura Wooden, Senior Supervisor
press@researchandmarkets.com
For E.S.T Workplace Hours Name +1-917-300-0470
For U.S./CAN Toll Free Name +1-800-526-8630
For GMT Workplace Hours Name +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outdoors U.S.): +353-1-481-1716
Emblem: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View unique content material:https://www.prnewswire.com/news-releases/malaysia-singapore-and-indonesia-in-vitro-diagnostics-ivd-market-report-2022-with-market-share-of-leading-players—roche-abbott-siemens-healthineers-beckman-coulter-biomerieux-bio-rad-sysmex-301710553.html
SOURCE Analysis and Markets
[ad_2]
Source link